InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Durso Jerome Benedict, Chief Executive Officer. Insider active across 1 company, notably Intercept Pharmaceuticals, INC.. Aggregated, 11 filings have been logged. Activity tracked since 1 July 2021. The latest transaction was disclosed on 8 November 2023 (U). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
51,815 shares@ US$19.0077.9% of flowCommon StockSEC:0001104659-23-117096:0
50,400 shares0Common StockSEC:0001104659-23-008582:0
7,083 shares@ US$12.377.0% of flowCommon StockSEC:0001104659-23-000329:0
35,700 shares0Common StockSEC:0001104659-22-009555:0
35,700 shares0Common StockSEC:0001104659-22-009555
5,607 shares@ US$16.296.8% of flowCommon StockSEC:0001104659-22-000917
5,607 shares@ US$16.2945.1% of flowCommon StockSEC:0001104659-22-000917:0
289 shares@ US$15.222.1% of flowCommon StockSEC:0001104659-21-123209:0
289 shares@ US$15.220.3% of flowCommon StockSEC:0001104659-21-123209
289 shares@ US$20.472.8% of flowCommon StockSEC:0001104659-21-089031:0
289 shares@ US$20.470.4% of flowCommon StockSEC:0001104659-21-089031
11 of 11 declarations
About Durso Jerome Benedict
Jerome Benedict Durso is the President and Chief Executive Officer of Intercept Pharmaceuticals, Inc. He leads the company's strategic efforts and oversees its operations. Durso is recognized for his expertise in the pharmaceutical field and his commitment to innovation and the development of new treatments.
